Investing in global measles and rubella elimination is needed to avert deaths and advance health equity

Investing in global measles and rubella elimination is needed to avert deaths and advance health equity

Bibliographic Details
Main Authors:	Pratima L Raghunathan, Walter Orenstein
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	The Lancet Global Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214109X22003886

Similar Items

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
by: T Jacob John
Published: (2023-01-01)

Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach
by: James L. Goodson, et al.
Published: (2017-12-01)

Measles and rubella in the North-West of Russia in period of elimination
by: M. A. Bichurina, et al.
Published: (2021-12-01)

Europe is Closer than Ever to Eliminating Measles and Rubella
by: Editorial Article
Published: (2016-04-01)

IMPROVEMENT OF THE QUALITY CONTROL OF ELISA TESTING FOR THE LABORATORY CONFIRMATION OF MEASLES AND RUBELLA INFECTIONS AT THE STAGE OF THE MEASLES/ RUBELLA ELIMINATION PROGRAM
by: T. A. Mamaeva, et al.
Published: (2017-03-01)

Decreases in Congenital Rubella Syndrome Reflect Concerted Efforts Toward Rubella and Measles Elimination
by: Gavin B. Grant, et al.
Published: (2023-12-01)

Europe Making Steady Progress Toward Measles and Rubella Elimination
by: Editorial Article
Published: (2016-12-01)

MEASLES AND RUBELLA IN NORTH-WEST REGION OF RUSSIA AT THE STAGE OF ELIMINATION
by: M. Bichurina, et al.
Published: (2018-12-01)

Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
by: Santosh Kumar Verma, et al.
Published: (2023-01-01)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
by: Mark Jit, et al.
Published: (2023-07-01)

Regional Meeting on Measles and Rubella
by: Editorial article
Published: (2018-04-01)

Why are measles and rubella returning in Brazil?
by: LYSANDRO P. BORGES, et al.
Published: (2023-12-01)

Estimating the future global dose demand for measles–rubella microarray patches
by: Melissa Ko, et al.
Published: (2023-01-01)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
by: Muhammad Suleman Rana, et al.
Published: (2022-11-01)

Clinical safety issues of measles, mumps and rubella vaccines
by: M.A. Afzal, et al.
Published: (2000-01-01)

DETECTION OF MEASLES AND RUBELLA ANTIBODIES IN DRIED BLOOD SPOTS
by: Stefka Krumova, et al.
Published: (2018-12-01)

Cost of conducting Measles-Rubella vaccination campaign in India
by: Susmita Chatterjee, et al.
Published: (2022-01-01)

Manifestations of the Epidemic Process of Measles and Rubella at the Present Stage
by: A. A. Pozdnyakov, et al.
Published: (2018-10-01)

Toward Rubella and Congenital Rubella Syndrome Control and Elimination – Worldwide
by: article Editorial
Published: (2019-11-01)

INCIDENCE OF RUBELLA IN NORTH WEST RUSSIA ON THE STAGE OF ELIMINATION OF RUBELLA
by: M. A. Bichurina, et al.
Published: (2014-08-01)

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
by: Emilia Vynnycky, et al.
Published: (2019-02-01)

Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII
by: Barbara J. Kuter, et al.
Published: (2021-12-01)

Genetic diversity of rubella virus at the present stage of rubella elimination and congenital rubella prevention programs
by: T. S. Chekhlyaeva, et al.
Published: (2019-11-01)

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
by: SHEN Jinhua, et al.
Published: (2022-05-01)

Science vs ‘‘scaremongering’’ over measles-mumps-rubella vaccine
by: Jacqui Wise
Published: (2001-01-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

The State of Specific Immunity to Measles and Rubella Virus in Newborns and their mothers
by: N. T. Tikhonova, et al.
Published: (2017-12-01)

Improving the Epidemiological Surveillance of Measles, Rubella and Mumps in the Russian Federation
Published: (2023-01-01)

Domestic Tetravaccine (Measles-Rubella-Mumps) – Immunization of Premature Babies
by: V. V. Semerikov, et al.
Published: (2022-09-01)

INFLUENCE OF POPULATION IMMUNITY PECULIARITIES ON THE STRUCTURE OF MEASLES AND RUBELLA PREVALENCE
by: A. P. Toptygina, et al.
Published: (2018-11-01)

DETERMINANTS OF PARENT’S DECISIONS IN IMMUNIZING MEASLES RUBELLA (MR) VACCINE
by: Devi Maya Arista, et al.
Published: (2021-09-01)

Measles, mumps, rubella vaccination experience in infants with egg allergy
by: Esra Hazar Sayar
Published: (2019-10-01)

The Investigation of Seroprevalence of Measles, Rubella, Mumps, and Varicella in Medical Students
by: Şebnem ÇALIK, et al.
Published: (2017-06-01)

Early Onset Optic Neuritis Following Measles-Rubella Vaccination
by: Siamak Moradian, et al.
Published: (2008-12-01)

Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
by: Malorie Perry, et al.
Published: (2023-03-01)

Progress in Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2000 - 2016
by: Editorial Article
Published: (2017-12-01)

Pervasive Parental Hesitancy and Resistance towards Measles Rubella Vaccination in Jordan
by: Muna Barakat, et al.
Published: (2023-10-01)

Response to Measles, Mumps and Rubella (MMR) Vaccine in Transfusion-Dependent Patients
by: Maddalena Casale, et al.
Published: (2021-05-01)

STATE OF MEASLES, RUBELLA AND MUMPS IN THE SARATOV REGION IN 2001—2013 YEARS
by: T. N. Buchkova, et al.
Published: (2015-08-01)

Post Vaccine Rubella During a Measles Outbreak: Clinical Case
by: Luísa Graça, et al.
Published: (2021-02-01)